Lee Scott Golden Sells $57.7K of PTC Therapeutics Inc (PTCT) — SEC Form 4, Jan 10, 2024

Open-Market Net Sale · SEC Form 4
−$57,739
10b5-1 Plan

Equity position changed by -5.0%

Reporting Owner
TXN 2024-01-09 · FILED 2024-01-10
Equity Position 37.9K sh 39,914 → 37,914
Equity Change -5.0% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2024-01-10
Report Date
2024-01-08
Accession No.
0001415889-24-000913
Accepted At
2024-01-10 21:06 UTC
Reporting Owner
Name Relationship
Lee Scott Golden CIK 0001686217
Officer
Lee Scott Golden at PTC Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $1,081,515
More from this insider at PTC Therapeutics Inc
2026-04-06 Sell -$56,364 View
2026-03-09 Sell -$633,800 View
2026-02-20 Sell -$172,290 View
2026-01-12 Sell -$66,206 View
2026-01-08 Sell -$152,855 View
All filings by this insider at PTC Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2024-01-08 S - Sale 10b5-1 775 D $28.64 -$22,196 39,139 Direct
Common StockF3 2024-01-09 S - Sale 10b5-1 1,225 D $29.01 -$35,543 37,914 Direct
Footnotes (3)
F1
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs. Show more
F2
Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023. Show more
F3
Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs and the vesting of 3,539 RSUs from January 7, 2022 grants totaling14,155 RSUs. Show more
5%+ Holders · 13D/G 5 filers
Other insiders at PTC Therapeutics Inc
All PTC Therapeutics Inc insider activity
GET /v1/forms/4/0001415889-24-000913 API docs
View Original SEC Filing